Recently, we demonstrated that during mid-gestation the combined exposure to DHT and INS mimics the in vivo hyperandrogenism and insulin resistance seen in humans and increases mitochondrial abnormalities in the gravid uterus and placenta [29–31]. The gene discussed is INS; the disease is hyperandrogenism.